Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes-Reference-Cited by-同舟云学术

Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes

Published:2023-06 Issue:6 Volume:4 Page:101055
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Cunnea Paula^ORCID,Curry Edward W.,Christie Elizabeth L.,Nixon Katherine,Kwok Chun Hei,Pandey Ahwan,Wulandari Ratri,Thol Kerstin,Ploski Jennifer,Morera-Albert Cristina,McQuaid Stephen,Lozano-Kuehne Jingky,Clark James J.,Krell Jonathan,Stronach Euan A.,McNeish Iain A.,Bowtell David D.L.,Fotopoulou Christina

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference69 articles.

1. Maximal-effort cytoreductive surgery for ovarian cancer patients with a high tumor burden: variations in practice and impact on outcome;Hall;Ann. Surg Oncol.,2019

2. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

3. Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update;Fotopoulou;Int. J. Gynecol. Cancer,2020

4. PARP inhibition as frontline therapy in ovarian cancer;Moore;Clin. Adv. Hematol. Oncol.,2020

5. New challenges in psycho-oncology: using drug development methodology to improve survivorship and supportive care intervention trials;Howells;Psycho Oncol.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04

2. Quantifying Intratumoral Biomarker Heterogeneity in Tubo-ovarian High-grade Serous Carcinoma to Optimize Clinical Translation;2024-08-13

3. Cell‐free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer;Molecular Oncology;2024-08-08

4. Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance;Biomedicine & Pharmacotherapy;2024-08

5. Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group;Frontiers in Oncology;2024-06-04